{
    "abstract": "Background: This study evaluated the immunogenicity and safety of quadrivalent meningococcal conjugate vaccine using tetanus (T) toxoid as carrier protein (MenACWY-TT) co-administered with combined diphtheria-tetanus-acellular pertussis vaccine (Tdap) versus their separate administration in adolescents and young adults. Methods: In this phase III, randomized, partially-blind study (NCT01767376), healthy 11\u201325-year-olds (N = 660) were randomized (1:1:1) to receive MenACWY-TT and Tdap at Month 0 (Co-ad group), MenACWY-TT at Month 0 and Tdap at Month 1 (ACWY_Tdap group) or Tdap at Month 0 and MenACWY-TT at Month 1 (Tdap_ACWY group). Immune responses to MenACWY-TT were measured by serum bactericidal assay using rabbit complement (rSBA). Anti-diphtheria (D), anti-tetanus (T), anti-pertussis toxin (PT), anti-filamentous hemagglutinin (FHA) and anti-pertactin (PRN) antibody concentrations were assessed using enzyme-linked immunosorbent assays. Non-inferiority of immunogenicity was assessed using pre-defined clinical criteria. Safety was also evaluated. Results: Non-inferiority of immunogenicity of MenACWY-TT and Tdap when co-administered versus their separate administration was demonstrated in terms of rSBA geometric mean titers (GMTs) for 4 meningococcal serogroups and of the percentage of participants with antibody concentrations >1 IU/ml for D and T. Among the pertussis antigens, non-inferiority criteria for geometric mean concentrations (GMCs) were reached for PT, but not met for FHA and PRN. Across all groups, \u226593.2% of participants had vaccine responses to each meningococcal serogroup, \u226599.1% were seroprotected against T and D, and \u226585.5% had booster responses to each pertussis antigen. Robust increases in antibody GMTs/GMCs were observed for all antigens between pre-and post-vaccination. Both vaccines had clinically acceptable safety profiles. Conclusion: Immune responses to MenACWY-TT and to the T and D antigens from Tdap were not impacted by their co-administration. The lower antibody concentrations observed against the pertussis components may be of limited clinical relevance since robust anti-pertussis booster responses were observed. This study supports concurrent administration of the 2 vaccines in adolescents.",
    "author_highlights": [
        {
            "endOffset": 18889,
            "sentence": "We evaluated the co-administration of MenACWY-TT and Tdap in 11\u201325-year-olds.",
            "startOffset": 18812
        },
        {
            "endOffset": 18974,
            "sentence": "Co-administration did not impact immune response to MenACWY-TT, diphtheria, tetanus.",
            "startOffset": 18890
        },
        {
            "endOffset": 19055,
            "sentence": "Anti-pertussis antibody concentrations seemed lower following co-administration.",
            "startOffset": 18975
        },
        {
            "endOffset": 19134,
            "sentence": "Robust post-Tdap anti-pertussis booster responses were observed in all groups.",
            "startOffset": 19056
        },
        {
            "endOffset": 19207,
            "sentence": "Both vaccines had a clinically acceptable safety profile in both groups.",
            "startOffset": 19135
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Vassiliki",
                    "initial": "V.",
                    "last": "Papaevangelou"
                },
                {
                    "first": "Nikos",
                    "initial": "N.",
                    "last": "Spyridis"
                }
            ],
            "doi": "10.1586/erv.12.32",
            "firstpage": "523",
            "issn": "14760584",
            "lastpage": "537",
            "pmid": "22827239",
            "pub_year": 2012,
            "title": "MenACWY-TT vaccine for active immunization against invasive meningococcal disease",
            "volume": "11"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Lee H.",
                    "initial": "L.H.",
                    "last": "Harrison"
                },
                {
                    "first": "Caroline L.",
                    "initial": "C.L.",
                    "last": "Trotter"
                },
                {
                    "first": "Mary E.",
                    "initial": "M.E.",
                    "last": "Ramsay"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.04.063",
            "firstpage": "B51",
            "issn": "0264410X",
            "lastpage": "B63",
            "pmid": "19477562",
            "pub_year": 2009,
            "title": "Global epidemiology of meningococcal disease",
            "volume": "27"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Rabab Z.",
                    "initial": "R.Z.",
                    "last": "Jafri"
                },
                {
                    "first": "Asad",
                    "initial": "A.",
                    "last": "Ali"
                },
                {
                    "first": "Nancy E.",
                    "initial": "N.E.",
                    "last": "Messonnier"
                },
                {
                    "first": "Carol",
                    "initial": "C.",
                    "last": "Tevi-Benissan"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Durrheim"
                },
                {
                    "first": "Juhani",
                    "initial": "J.",
                    "last": "Eskola"
                },
                {
                    "first": "Florence",
                    "initial": "F.",
                    "last": "Fermon"
                },
                {
                    "first": "Keith P.",
                    "initial": "K.P.",
                    "last": "Klugman"
                },
                {
                    "first": "Mary",
                    "initial": "M.",
                    "last": "Ramsay"
                },
                {
                    "first": "Samba",
                    "initial": "S.",
                    "last": "Sow"
                },
                {
                    "first": "Shao",
                    "initial": "S.",
                    "last": "Zhujun"
                },
                {
                    "first": "Zulfiqar A.",
                    "initial": "Z.A.",
                    "last": "Bhutta"
                },
                {
                    "first": "Jon",
                    "initial": "J.",
                    "last": "Abramson"
                }
            ],
            "doi": "10.1186/1478-7954-11-17",
            "issn": "14787954",
            "pub_year": 2013,
            "title": "Global epidemiology of invasive meningococcal disease",
            "volume": "11"
        },
        "b0020": null,
        "b0025": {
            "authors": [
                {
                    "first": "Marco Aur\u00e9lio P.",
                    "initial": "M.A.P.",
                    "last": "S\u00e1fadi"
                },
                {
                    "first": "Miguel",
                    "initial": "M.",
                    "last": "O'Ryan"
                },
                {
                    "first": "Maria Teresa",
                    "initial": "M.T.",
                    "last": "Valenzuela Bravo"
                },
                {
                    "first": "Maria Cristina C.",
                    "initial": "M.C.C.",
                    "last": "Brandileone"
                },
                {
                    "first": "Maria Cec\u00edlia O.",
                    "initial": "M.C.O.",
                    "last": "Gorla"
                },
                {
                    "first": "Ana Paula S.",
                    "initial": "A.P.S.",
                    "last": "de Lemos"
                },
                {
                    "first": "Gabriela",
                    "initial": "G.",
                    "last": "Moreno"
                },
                {
                    "first": "Julio A.",
                    "initial": "J.A.",
                    "last": "Vazquez"
                },
                {
                    "first": "Eduardo L.",
                    "initial": "E.L.",
                    "last": "L\u00f3pez"
                },
                {
                    "first": "Muhamed Kheir",
                    "initial": "M.K.",
                    "last": "Taha"
                },
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Borrow"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1016/j.vaccine.2015.10.055",
            "firstpage": "6529",
            "issn": "0264410X",
            "lastpage": "6536",
            "pmid": "26597036",
            "pub_year": 2015,
            "title": "The current situation of meningococcal disease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations",
            "volume": "33"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Kylie S.",
                    "initial": "K.S.",
                    "last": "Carville"
                },
                {
                    "first": "Kerrie",
                    "initial": "K.",
                    "last": "Stevens"
                },
                {
                    "first": "Asma",
                    "initial": "A.",
                    "last": "Sohail"
                },
                {
                    "first": "Lucinda J.",
                    "initial": "L.J.",
                    "last": "Franklin"
                },
                {
                    "first": "Katherine A.",
                    "initial": "K.A.",
                    "last": "Bond"
                },
                {
                    "first": "Aicha",
                    "initial": "A.",
                    "last": "Brahmi"
                },
                {
                    "first": "Finn",
                    "initial": "F.",
                    "last": "Romanes"
                },
                {
                    "first": "Katherine S.",
                    "initial": "K.S.",
                    "last": "Ong"
                }
            ],
            "doi": "10.3201/eid2210.151935",
            "firstpage": "1785",
            "issn": "10806040",
            "lastpage": "1787",
            "pmid": "27648521",
            "pub_year": 2016,
            "title": "Increase in meningococcal serogroup W Disease, Victoria, Australia, 2013\u20132015",
            "volume": "22"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Stephen I.",
                    "initial": "S.I.",
                    "last": "Pelton"
                }
            ],
            "doi": "10.1016/j.jadohealth.2016.04.012",
            "firstpage": "S3",
            "issn": "1054139X",
            "lastpage": "S11",
            "pmid": "27449148",
            "pub_year": 2016,
            "title": "The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines",
            "volume": "59"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Yorgo C.",
                    "initial": "Y.C.",
                    "last": "Zahlanie"
                },
                {
                    "first": "Moza M.",
                    "initial": "M.M.",
                    "last": "Hammadi"
                },
                {
                    "first": "Soha T.",
                    "initial": "S.T.",
                    "last": "Ghanem"
                },
                {
                    "first": "Ghassan S.",
                    "initial": "G.S.",
                    "last": "Dbaibo"
                }
            ],
            "doi": "10.4161/hv.27739",
            "firstpage": "995",
            "issn": "21645515",
            "lastpage": "1007",
            "pmid": "24500529",
            "pub_year": 2014,
            "title": "Review of meningococcal vaccines with updates on immunization in adults",
            "volume": "10"
        },
        "b0045": null,
        "b0050": {
            "authors": [
                {
                    "first": "Aia",
                    "initial": "A.",
                    "last": "Assaf-Casals"
                },
                {
                    "first": "Ghassan",
                    "initial": "G.",
                    "last": "Dbaibo"
                }
            ],
            "doi": "10.1080/21645515.2016.1143157",
            "firstpage": "1825",
            "issn": "21645515",
            "lastpage": "1837",
            "pmid": "26900984",
            "pub_year": 2016,
            "title": "Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, Nimenrix\u2122): A review of its immunogenicity, safety, co-administration, and antibody persistence",
            "volume": "12"
        },
        "b0055": {
            "authors": [
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Pace"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "Pollard"
                }
            ],
            "doi": "10.1136/adc.2006.111500",
            "firstpage": "909",
            "issn": "00039888",
            "lastpage": "915",
            "pmid": "17895339",
            "pub_year": 2007,
            "title": "Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines",
            "volume": "92"
        },
        "b0060": null,
        "b0065": null,
        "b0070": {
            "authors": [
                {
                    "first": "Natalia",
                    "initial": "N.",
                    "last": "Ilyina"
                },
                {
                    "first": "Susanna",
                    "initial": "S.",
                    "last": "Kharit"
                },
                {
                    "first": "Leila",
                    "initial": "L.",
                    "last": "Namazova-Baranova"
                },
                {
                    "first": "Asmik",
                    "initial": "A.",
                    "last": "Asatryan"
                },
                {
                    "first": "Mayya",
                    "initial": "M.",
                    "last": "Benashvili"
                },
                {
                    "first": "Elmira",
                    "initial": "E.",
                    "last": "Tkhostova"
                },
                {
                    "first": "Chiranjiwi",
                    "initial": "C.",
                    "last": "Bhusal"
                },
                {
                    "first": "Ashwani Kumar",
                    "initial": "A.K.",
                    "last": "Arora"
                }
            ],
            "doi": "10.4161/hv.29571",
            "firstpage": "2471",
            "issn": "21645515",
            "lastpage": "2481",
            "pmid": "25424958",
            "pub_year": 2014,
            "title": "Safety and immunogenicity of meningococcal ACWY CRM197-conjugate vaccine in children, adolescents and adults in Russia",
            "volume": "10"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Brian",
                    "initial": "B.",
                    "last": "Cooper"
                },
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "Detora"
                },
                {
                    "first": "Jeffrey",
                    "initial": "J.",
                    "last": "Stoddard"
                }
            ],
            "doi": "10.1586/erv.10.147",
            "firstpage": "21",
            "issn": "14760584",
            "lastpage": "33",
            "pmid": "21162617",
            "pub_year": 2011,
            "title": "Menveo\u00ae: A novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and y",
            "volume": "10"
        },
        "b0080": null,
        "b0085": {
            "authors": [
                {
                    "first": "Volker",
                    "initial": "V.",
                    "last": "Vetter"
                },
                {
                    "first": "Roger",
                    "initial": "R.",
                    "last": "Baxter"
                },
                {
                    "first": "G\u00fclhan",
                    "initial": "G.",
                    "last": "Denizer"
                },
                {
                    "first": "Marco A.P.",
                    "initial": "M.A.P.",
                    "last": "S\u00e1fadi"
                },
                {
                    "first": "Sven Arne",
                    "initial": "S.A.",
                    "last": "Silfverdal"
                },
                {
                    "first": "Andrew",
                    "initial": "A.",
                    "last": "Vyse"
                },
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Borrow"
                }
            ],
            "doi": "10.1586/14760584.2016.1130628",
            "firstpage": "641",
            "issn": "14760584",
            "lastpage": "658",
            "pmid": "26651380",
            "pub_year": 2016,
            "title": "Routinely vaccinating adolescents against meningococcus: Targeting transmission & disease",
            "volume": "15"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Grace M.",
                    "initial": "G.M.",
                    "last": "Lee"
                },
                {
                    "first": "Suchita",
                    "initial": "S.",
                    "last": "A.lorick"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Pfoh"
                },
                {
                    "first": "Ken",
                    "initial": "K.",
                    "last": "Kleinman"
                },
                {
                    "first": "Daniel",
                    "initial": "D.",
                    "last": "Fishbein"
                }
            ],
            "doi": "10.1542/peds.2007-2857",
            "firstpage": "711",
            "issn": "00314005",
            "lastpage": "717",
            "pmid": "18829792",
            "pub_year": 2008,
            "title": "Adolescent immunizations: Missed opportunities for prevention",
            "volume": "122"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Gary S.",
                    "initial": "G.S.",
                    "last": "Marshall"
                },
                {
                    "first": "Laura E.",
                    "initial": "L.E.",
                    "last": "Happe"
                },
                {
                    "first": "Orsolya E.",
                    "initial": "O.E.",
                    "last": "Lunacsek"
                },
                {
                    "first": "Michael D.",
                    "initial": "M.D.",
                    "last": "Szymanski"
                },
                {
                    "first": "Charles R.",
                    "initial": "C.R.",
                    "last": "Woods"
                },
                {
                    "first": "Matthew",
                    "initial": "M.",
                    "last": "Zahn"
                },
                {
                    "first": "Argartha",
                    "initial": "A.",
                    "last": "Russell"
                }
            ],
            "doi": "10.1097/INF.0b013e31805d7f17",
            "firstpage": "496",
            "issn": "08913668",
            "lastpage": "500",
            "pmid": "17529866",
            "pub_year": 2007,
            "title": "Use of combination vaccines is associated with improved coverage rates",
            "volume": "26"
        },
        "b0100": {
            "authors": [
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Schrauder"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Claus"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Elias"
                },
                {
                    "first": "U.",
                    "initial": "U.",
                    "last": "Vogel"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Haas"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Hellenbrand"
                }
            ],
            "doi": "10.1017/S0950268806007151",
            "firstpage": "657",
            "issn": "09502688",
            "lastpage": "664",
            "pmid": "16938141",
            "pub_year": 2007,
            "title": "Capture-recapture analysis to estimate the incidence of invasive meningococcal disease in Germany, 2003",
            "volume": "135"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Ana Bel\u00e9n",
                    "initial": "A.B.",
                    "last": "Ibarz-Pav\u00f3n"
                },
                {
                    "first": "Ana Paula",
                    "initial": "A.P.",
                    "last": "Lemos"
                },
                {
                    "first": "Maria Cecilia",
                    "initial": "M.C.",
                    "last": "Gorla"
                },
                {
                    "first": "Mabel",
                    "initial": "M.",
                    "last": "Regueira"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Corso"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Gagetti"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Efron"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Sorohuet"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Moscoloni"
                },
                {
                    "first": "P. R.",
                    "initial": "P.R.",
                    "last": "Rojas"
                },
                {
                    "first": "M. C.",
                    "initial": "M.C.",
                    "last": "Brandileone"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Maldonado"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Prat"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Seoane"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Araya"
                },
                {
                    "first": "M. E.",
                    "initial": "M.E.",
                    "last": "Realpe"
                },
                {
                    "first": "O. M.",
                    "initial": "O.M.",
                    "last": "Sanabria"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Duarte"
                },
                {
                    "first": "G. C.",
                    "initial": "G.C.",
                    "last": "Chacon"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Llanes"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Tora\u00f1o"
                },
                {
                    "first": "O.",
                    "initial": "O.",
                    "last": "Feliciano"
                },
                {
                    "first": "O.",
                    "initial": "O.",
                    "last": "Guti\u00e9rrez"
                },
                {
                    "first": "C. P.",
                    "initial": "C.P.",
                    "last": "Almeida"
                },
                {
                    "first": "Y. N.",
                    "initial": "Y.N.",
                    "last": "San Mart\u00edn"
                },
                {
                    "first": "J. S.",
                    "initial": "J.S.",
                    "last": "Ch\u00f3ez"
                },
                {
                    "first": "Z. J.",
                    "initial": "Z.J.",
                    "last": "de Fuentes"
                },
                {
                    "first": "R. E.",
                    "initial": "R.E.",
                    "last": "Castillo"
                },
                {
                    "first": "M. V.",
                    "initial": "M.V.",
                    "last": "Terrazas"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Ech\u00e1niz-Avil\u00e9s"
                },
                {
                    "first": "M. J.",
                    "initial": "M.J.",
                    "last": "Sandino"
                },
                {
                    "first": "A. O.",
                    "initial": "A.O.",
                    "last": "G\u00f3mez"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "de Quinzada"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "de Bola\u00f1os"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Fernandez"
                },
                {
                    "first": "G. A.",
                    "initial": "G.A.",
                    "last": "Chamorro Cortesi"
                },
                {
                    "first": "M. E.",
                    "initial": "M.E.",
                    "last": "Le\u00f3n Ayala"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Kawabata"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Morales"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "S\u00e1nchez"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Pe\u00f1a"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Nurse-Lucas"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Francis"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Camou"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "P\u00e9rez-Giffoni"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Spadola"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Payares"
                },
                {
                    "first": "C. I.",
                    "initial": "C.I.",
                    "last": "Agudelo"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Casta\u00f1eda"
                },
                {
                    "first": "Jean Marc",
                    "initial": "J.M.",
                    "last": "Gabastou"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1371/journal.pone.0044102",
            "issn": "19326203",
            "pmid": "22952888",
            "pub_year": 2012,
            "title": "Laboratory-Based Surveillance of Neisseria meningitidis Isolates from Disease Cases in Latin American and Caribbean Countries, SIREVA II 2006-2010",
            "volume": "7"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Jin Han",
                    "initial": "J.H.",
                    "last": "Kang"
                },
                {
                    "first": "Yan",
                    "initial": "Y.",
                    "last": "Miao"
                },
                {
                    "first": "Soo Young",
                    "initial": "S.Y.",
                    "last": "Lee"
                },
                {
                    "first": "Jong Hyun",
                    "initial": "J.H.",
                    "last": "Kim"
                },
                {
                    "first": "Kyung Yil",
                    "initial": "K.Y.",
                    "last": "Lee"
                },
                {
                    "first": "Sang Hyuk",
                    "initial": "S.H.",
                    "last": "Ma"
                },
                {
                    "first": "Dae Sun",
                    "initial": "D.S.",
                    "last": "Jo"
                },
                {
                    "first": "Hyo Young",
                    "initial": "H.Y.",
                    "last": "Song"
                },
                {
                    "first": "Mendel",
                    "initial": "M.",
                    "last": "Haag"
                }
            ],
            "doi": "10.3947/ic.2016.48.1.12",
            "firstpage": "12",
            "issn": "20932340",
            "lastpage": "19",
            "pub_year": 2016,
            "title": "A survey of serum bactericidal antibodies against neisseria meningitidis serogroups A, C, W and Y in adolescents and adults in the Republic of Korea",
            "volume": "48"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Borrow"
                },
                {
                    "first": "Jin Soo",
                    "initial": "J.S.",
                    "last": "Lee"
                },
                {
                    "first": "Julio A.",
                    "initial": "J.A.",
                    "last": "V\u00e1zquez"
                },
                {
                    "first": "Godwin",
                    "initial": "G.",
                    "last": "Enwere"
                },
                {
                    "first": "Muhamed Kheir",
                    "initial": "M.K.",
                    "last": "Taha"
                },
                {
                    "first": "Hajime",
                    "initial": "H.",
                    "last": "Kamiya"
                },
                {
                    "first": "Hwang Min",
                    "initial": "H.M.",
                    "last": "Kim"
                },
                {
                    "first": "Dae Sun",
                    "initial": "D.S.",
                    "last": "Jo"
                }
            ],
            "doi": "10.1016/j.vaccine.2016.10.022",
            "firstpage": "5855",
            "issn": "0264410X",
            "lastpage": "5862",
            "pmid": "27780631",
            "pub_year": 2016,
            "title": "Meningococcal disease in the Asia-Pacific region: Findings and recommendations from the Global Meningococcal Initiative",
            "volume": "34"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Han Wool",
                    "initial": "H.W.",
                    "last": "Kim"
                },
                {
                    "first": "Soyoung",
                    "initial": "S.",
                    "last": "Lee"
                },
                {
                    "first": "Daeho",
                    "initial": "D.",
                    "last": "Kwon"
                },
                {
                    "first": "Jihei",
                    "initial": "J.",
                    "last": "Cha"
                },
                {
                    "first": "Jong Gyun",
                    "initial": "J.G.",
                    "last": "Ahn"
                },
                {
                    "first": "Kyung Hyo",
                    "initial": "K.H.",
                    "last": "Kim"
                }
            ],
            "doi": "10.3346/jkms.2017.32.7.1111",
            "firstpage": "1111",
            "issn": "10118934",
            "lastpage": "1117",
            "pmid": "28581267",
            "pub_year": 2017,
            "title": "Characterization of oropharyngeal carriage isolates of Neisseria meningitidis in healthy Korean adolescents in 2015",
            "volume": "32"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Nick",
                    "initial": "N.",
                    "last": "Andrews"
                },
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Borrow"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1128/CDLI.10.5.780-786.2003",
            "firstpage": "780",
            "issn": "1071412X",
            "lastpage": "786",
            "pmid": "12965904",
            "pub_year": 2003,
            "title": "Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England",
            "volume": "10"
        },
        "b0130": null,
        "b0135": {
            "authors": [
                {
                    "first": "Christopher J.",
                    "initial": "C.J.",
                    "last": "Gill"
                },
                {
                    "first": "Roger",
                    "initial": "R.",
                    "last": "Baxter"
                },
                {
                    "first": "Alessandra",
                    "initial": "A.",
                    "last": "Anemona"
                },
                {
                    "first": "Giuseppe L.",
                    "initial": "G.L.",
                    "last": "Ciavarro"
                },
                {
                    "first": "Peter M.",
                    "initial": "P.M.",
                    "last": "Dull"
                }
            ],
            "doi": "10.4161/hv.6.11.12849",
            "firstpage": "881",
            "issn": "15548600",
            "lastpage": "887",
            "pmid": "21339701",
            "pub_year": 2010,
            "title": "Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo\u00ae) or Menactra\u00ae among healthy adolescents",
            "volume": "6"
        },
        "b0140": {
            "authors": [
                {
                    "first": "E. D.G.",
                    "initial": "E.D.G.",
                    "last": "McIntosh"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Br\u00f6ker"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Wassil"
                },
                {
                    "first": "J. A.",
                    "initial": "J.A.",
                    "last": "Welsch"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Borrow"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.07.019",
            "firstpage": "4414",
            "issn": "0264410X",
            "lastpage": "4421",
            "pmid": "26187262",
            "pub_year": 2015,
            "title": "Serum bactericidal antibody assays - The role of complement in infection and immunity",
            "volume": "33"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Gianni",
                    "initial": "G.",
                    "last": "Bona"
                },
                {
                    "first": "Paolo",
                    "initial": "P.",
                    "last": "Castiglia"
                },
                {
                    "first": "Giorgio",
                    "initial": "G.",
                    "last": "Zoppi"
                },
                {
                    "first": "Maurizio",
                    "initial": "M.",
                    "last": "de Martino"
                },
                {
                    "first": "Annaelisa",
                    "initial": "A.",
                    "last": "Tasciotti"
                },
                {
                    "first": "Diego",
                    "initial": "D.",
                    "last": "D'Agostino"
                },
                {
                    "first": "Linda",
                    "initial": "L.",
                    "last": "Han"
                },
                {
                    "first": "Igor",
                    "initial": "I.",
                    "last": "Smolenov"
                }
            ],
            "doi": "10.1016/j.vaccine.2016.05.009",
            "firstpage": "3363",
            "issn": "0264410X",
            "lastpage": "3370",
            "pmid": "27181507",
            "pub_year": 2016,
            "title": "Safety and immunogenicity of a CRM or TT conjugated meningococcal vaccine in healthy toddlers",
            "volume": "34"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Stanley A.",
                    "initial": "S.A.",
                    "last": "Plotkin"
                }
            ],
            "doi": "10.1128/CVI.00131-10",
            "firstpage": "1055",
            "issn": "15566811",
            "lastpage": "1065",
            "pmid": "20463105",
            "pub_year": 2010,
            "title": "Correlates of protection induced by vaccination",
            "volume": "17"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Olli",
                    "initial": "O.",
                    "last": "Miettinen"
                },
                {
                    "first": "Markku",
                    "initial": "M.",
                    "last": "Nurminen"
                }
            ],
            "doi": "10.1002/sim.4780040211",
            "firstpage": "213",
            "issn": "02776715",
            "lastpage": "226",
            "pmid": "4023479",
            "pub_year": 1985,
            "title": "Comparative analysis of two rates",
            "volume": "4"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Michael P.",
                    "initial": "M.P.",
                    "last": "Broderick"
                },
                {
                    "first": "Sandra",
                    "initial": "S.",
                    "last": "Romero-Steiner"
                },
                {
                    "first": "Gowrisankar",
                    "initial": "G.",
                    "last": "Rajam"
                },
                {
                    "first": "Scott E.",
                    "initial": "S.E.",
                    "last": "Johnson"
                },
                {
                    "first": "Andrea",
                    "initial": "A.",
                    "last": "Milton"
                },
                {
                    "first": "Ellie",
                    "initial": "E.",
                    "last": "Kim"
                },
                {
                    "first": "Lisa J.",
                    "initial": "L.J.",
                    "last": "Choi"
                },
                {
                    "first": "Jennifer M.",
                    "initial": "J.M.",
                    "last": "Radin"
                },
                {
                    "first": "Daniel S.",
                    "initial": "D.S.",
                    "last": "Schmidt"
                },
                {
                    "first": "George M.",
                    "initial": "G.M.",
                    "last": "Carlone"
                },
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Messonnier"
                },
                {
                    "first": "Dennis J.",
                    "initial": "D.J.",
                    "last": "Faix"
                }
            ],
            "doi": "10.1128/CVI.00267-16",
            "firstpage": "672",
            "issn": "15566811",
            "lastpage": "680",
            "pmid": "27280619",
            "pub_year": 2016,
            "title": "Immune responses in U.S. military personnel who received meningococcal conjugate vaccine (MenACWY) concomitantly with other vaccines were higher than in personnel who received MenACWY alone",
            "volume": "23"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Markus",
                    "initial": "M.",
                    "last": "Knuf"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Pantazi-Chatzikonstantinou"
                },
                {
                    "first": "Ulrich",
                    "initial": "U.",
                    "last": "Pfletschinger"
                },
                {
                    "first": "Irmingard",
                    "initial": "I.",
                    "last": "Tichmann-Schumann"
                },
                {
                    "first": "Hartwig",
                    "initial": "H.",
                    "last": "Maurer"
                },
                {
                    "first": "Lothar",
                    "initial": "L.",
                    "last": "Maurer"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Fischbach"
                },
                {
                    "first": "Henrike",
                    "initial": "H.",
                    "last": "Zinke"
                },
                {
                    "first": "Heidemarie",
                    "initial": "H.",
                    "last": "Pankow-Culot"
                },
                {
                    "first": "Vassiliki",
                    "initial": "V.",
                    "last": "Papaevangelou"
                },
                {
                    "first": "Veronique",
                    "initial": "V.",
                    "last": "Bianco"
                },
                {
                    "first": "Marie",
                    "initial": "M.",
                    "last": "Van der Wielen"
                },
                {
                    "first": "Jacqueline M.",
                    "initial": "J.M.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.03.009",
            "firstpage": "4264",
            "issn": "0264410X",
            "lastpage": "4273",
            "pmid": "21420417",
            "pub_year": 2011,
            "title": "An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix\u2122 hexa is immunogenic, with an acceptable safety profile in 12-23-month-old children",
            "volume": "29"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Mohamed",
                    "initial": "M.",
                    "last": "Tashani"
                },
                {
                    "first": "Leon",
                    "initial": "L.",
                    "last": "Heron"
                },
                {
                    "first": "Melanie",
                    "initial": "M.",
                    "last": "Wong"
                },
                {
                    "first": "Harunor",
                    "initial": "H.",
                    "last": "Rashid"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Booy"
                }
            ],
            "doi": "10.1093/jtm/tax006",
            "issn": "11951982",
            "pmid": "28375507",
            "pub_year": 2017,
            "title": "Tetanus-diphtheria-pertussis vaccine may suppress the immune response to subsequent immunization with pneumococcal CRM197-conjugate vaccine (coadministered with quadrivalent meningococcal TT-conjugate vaccine): A randomized, controlled trial",
            "volume": "24"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Bermal"
                },
                {
                    "first": "Li Min",
                    "initial": "L.M.",
                    "last": "Huang"
                },
                {
                    "first": "Ashish P.",
                    "initial": "A.P.",
                    "last": "Dubey"
                },
                {
                    "first": "Hermant",
                    "initial": "H.",
                    "last": "Jain"
                },
                {
                    "first": "Ashish",
                    "initial": "A.",
                    "last": "Bavdekar"
                },
                {
                    "first": "Tzou Yien",
                    "initial": "T.Y.",
                    "last": "Lin"
                },
                {
                    "first": "Veronique",
                    "initial": "V.",
                    "last": "Bianco"
                },
                {
                    "first": "Yaela",
                    "initial": "Y.",
                    "last": "Baine"
                },
                {
                    "first": "Jacqueline M.",
                    "initial": "J.M.",
                    "last": "Miller"
                }
            ],
            "doi": "10.4161/hv.7.2.14068",
            "firstpage": "239",
            "issn": "15548600",
            "lastpage": "247",
            "pmid": "21343698",
            "pub_year": 2011,
            "title": "Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults",
            "volume": "7"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Charissa",
                    "initial": "C.",
                    "last": "Borja-Tabora"
                },
                {
                    "first": "Cecilia",
                    "initial": "C.",
                    "last": "Montalban"
                },
                {
                    "first": "Ziad A.",
                    "initial": "Z.A.",
                    "last": "Memish"
                },
                {
                    "first": "Marie",
                    "initial": "M.",
                    "last": "Van der Wielen"
                },
                {
                    "first": "Veronique",
                    "initial": "V.",
                    "last": "Bianco"
                },
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Boutriau"
                },
                {
                    "first": "Jacqueline",
                    "initial": "J.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1186/1471-2334-13-116",
            "issn": "14712334",
            "pmid": "23510357",
            "pub_year": 2013,
            "title": "Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: Results of an open, randomised, controlled study",
            "volume": "13"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Ghassan",
                    "initial": "G.",
                    "last": "Dbaibo"
                },
                {
                    "first": "Nabil",
                    "initial": "N.",
                    "last": "El-Ayoubi"
                },
                {
                    "first": "Soha",
                    "initial": "S.",
                    "last": "Ghanem"
                },
                {
                    "first": "Farah",
                    "initial": "F.",
                    "last": "Hajar"
                },
                {
                    "first": "Veronique",
                    "initial": "V.",
                    "last": "Bianco"
                },
                {
                    "first": "Jacqueline M.",
                    "initial": "J.M.",
                    "last": "Miller"
                },
                {
                    "first": "Narcisa",
                    "initial": "N.",
                    "last": "Mesaros"
                }
            ],
            "doi": "10.1007/s40266-013-0065-0",
            "firstpage": "309",
            "issn": "1170229X",
            "lastpage": "319",
            "pmid": "23494214",
            "pub_year": 2013,
            "title": "Immunogenicity and safety of a quadrivalent meningococcal serogroups A, C, W-135 and y tetanus toxoid conjugate vaccine (MenACWY-TT) administered to adults aged 56 years and older: Results of an open-label, randomized, controlled trial",
            "volume": "30"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Ziad A.",
                    "initial": "Z.A.",
                    "last": "Memish"
                },
                {
                    "first": "Ghassan",
                    "initial": "G.",
                    "last": "Dbaibo"
                },
                {
                    "first": "May",
                    "initial": "M.",
                    "last": "Montellano"
                },
                {
                    "first": "Valsan P.",
                    "initial": "V.P.",
                    "last": "Verghese"
                },
                {
                    "first": "Hemant",
                    "initial": "H.",
                    "last": "Jain"
                },
                {
                    "first": "A. P.",
                    "initial": "A.P.",
                    "last": "Dubey"
                },
                {
                    "first": "Veronique",
                    "initial": "V.",
                    "last": "Bianco"
                },
                {
                    "first": "Marie",
                    "initial": "M.",
                    "last": "Van der Wielen"
                },
                {
                    "first": "Salvacion",
                    "initial": "S.",
                    "last": "Gatchalian"
                },
                {
                    "first": "Jacqueline M.",
                    "initial": "J.M.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1097/INF.0b013e31820e6e02",
            "firstpage": "e56",
            "issn": "08913668",
            "lastpage": "e62",
            "pmid": "21278617",
            "pub_year": 2011,
            "title": "Immunogenicity of a single dose of tetravalent meningococcal serogroups a, c, w-135, and y conjugate vaccine administered to 2- to 10-year-olds is noninferior to a licensed-acwy polysaccharide vaccine with an acceptable safety profile",
            "volume": "30"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Timo",
                    "initial": "T.",
                    "last": "Vesikari"
                },
                {
                    "first": "Aino",
                    "initial": "A.",
                    "last": "Forst\u00e9n"
                },
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Boutriau"
                },
                {
                    "first": "V\u00e9ronique",
                    "initial": "V.",
                    "last": "Bianco"
                },
                {
                    "first": "Marie",
                    "initial": "M.",
                    "last": "Van Der Wielen"
                },
                {
                    "first": "Jacqueline M.",
                    "initial": "J.M.",
                    "last": "Miller"
                }
            ],
            "doi": "10.4161/hv.22165",
            "firstpage": "1882",
            "issn": "21645515",
            "lastpage": "1891",
            "pmid": "23032168",
            "pub_year": 2012,
            "title": "A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and y tetanus toxoid conjugate vaccine in children aged 2-10 y",
            "volume": "8"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Markus",
                    "initial": "M.",
                    "last": "Knuf"
                },
                {
                    "first": "Olivier",
                    "initial": "O.",
                    "last": "Romain"
                },
                {
                    "first": "Klaus",
                    "initial": "K.",
                    "last": "Kindler"
                },
                {
                    "first": "Uta",
                    "initial": "U.",
                    "last": "Walther"
                },
                {
                    "first": "Phu My",
                    "initial": "P.M.",
                    "last": "Tran"
                },
                {
                    "first": "Heidemarie",
                    "initial": "H.",
                    "last": "Pankow-Culot"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Fischbach"
                },
                {
                    "first": "Dorothee",
                    "initial": "D.",
                    "last": "Kieninger-Baum"
                },
                {
                    "first": "V\u00e9ronique",
                    "initial": "V.",
                    "last": "Bianco"
                },
                {
                    "first": "Yaela",
                    "initial": "Y.",
                    "last": "Baine"
                },
                {
                    "first": "Jacqueline",
                    "initial": "J.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1007/s00431-012-1924-0",
            "firstpage": "601",
            "issn": "03406199",
            "lastpage": "612",
            "pmid": "23307281",
            "pub_year": 2013,
            "title": "Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2-10-year-old children: Results of an open, randomised, controlled study",
            "volume": "172"
        },
        "b0205": {
            "authors": [
                {
                    "first": "Lars",
                    "initial": "L.",
                    "last": "\u00d8stergaard"
                },
                {
                    "first": "Edouard",
                    "initial": "E.",
                    "last": "Lebacq"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Poolman"
                },
                {
                    "first": "Gudrun",
                    "initial": "G.",
                    "last": "Maechler"
                },
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Boutriau"
                }
            ],
            "doi": "10.1016/j.vaccine.2008.08.075",
            "firstpage": "161",
            "issn": "0264410X",
            "lastpage": "168",
            "pmid": "18834910",
            "pub_year": 2009,
            "title": "Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15-25 years",
            "volume": "27"
        },
        "b0210": {
            "authors": [
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Findlow"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Borrow"
                }
            ],
            "doi": "10.1080/21645515.2015.1091908",
            "firstpage": "226",
            "issn": "21645515",
            "lastpage": "230",
            "pmid": "26619353",
            "pub_year": 2016,
            "title": "Interactions of conjugate vaccines and co-administered vaccines",
            "volume": "12"
        },
        "b0215": {
            "authors": [
                {
                    "first": "RICHARD A.",
                    "initial": "R.A.",
                    "last": "INSEL"
                }
            ],
            "doi": "10.1111/j.1749-6632.1995.tb44436.x",
            "firstpage": "35",
            "issn": "00778923",
            "lastpage": "48",
            "pmid": "7625671",
            "pub_year": 1995,
            "title": "Potential Alterations in Immunogenicity by Combining or Simultaneously Administering Vaccine Components",
            "volume": "754"
        },
        "b0220": null,
        "b0225": null,
        "b0230": {
            "authors": [
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Leonardi"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Latiolais"
                },
                {
                    "first": "Kwabena",
                    "initial": "K.",
                    "last": "Sarpong"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Simon"
                },
                {
                    "first": "Jerry",
                    "initial": "J.",
                    "last": "Twiggs"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Lei"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Rinderknecht"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Blatter"
                },
                {
                    "first": "Veronique",
                    "initial": "V.",
                    "last": "Bianco"
                },
                {
                    "first": "Yaela",
                    "initial": "Y.",
                    "last": "Baine"
                },
                {
                    "first": "Leonard R.",
                    "initial": "L.R.",
                    "last": "Friedland"
                },
                {
                    "first": "Carmen",
                    "initial": "C.",
                    "last": "Baccarini"
                },
                {
                    "first": "Jacqueline M.",
                    "initial": "J.M.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.09.064",
            "firstpage": "924",
            "issn": "0264410X",
            "lastpage": "932",
            "pmid": "25305567",
            "pub_year": 2015,
            "title": "Immunogenicity and reactogenicity of Infanrix\u2122 when co-administered with meningococcal MenACWY-TT conjugate vaccine in toddlers primed with MenHibrix\u2122 and Pediarix\u2122",
            "volume": "33"
        },
        "b0235": {
            "authors": [
                {
                    "first": "Timo",
                    "initial": "T.",
                    "last": "Vesikari"
                },
                {
                    "first": "Aino",
                    "initial": "A.",
                    "last": "Karvonen"
                },
                {
                    "first": "Veronique",
                    "initial": "V.",
                    "last": "Bianco"
                },
                {
                    "first": "Marie",
                    "initial": "M.",
                    "last": "Van der Wielen"
                },
                {
                    "first": "Jacqueline",
                    "initial": "J.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.03.043",
            "firstpage": "4274",
            "issn": "0264410X",
            "lastpage": "4284",
            "pmid": "21443965",
            "pub_year": 2011,
            "title": "Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life: An open, randomized controlled trial",
            "volume": "29"
        },
        "b0240": {
            "authors": [
                {
                    "first": "H. J.",
                    "initial": "H.J.",
                    "last": "Schmitt"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Schuind"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Knuf"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Beutel"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Schulte-Wissermann"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Gahr"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Schult"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Folkens"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Rauh"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Bogaerts"
                },
                {
                    "first": "H. L.",
                    "initial": "H.L.",
                    "last": "Bork"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Clemens"
                }
            ],
            "doi": "10.1016/S0022-3476(96)70152-X",
            "firstpage": "695",
            "issn": "00223476",
            "lastpage": "701",
            "pmid": "8917236",
            "pub_year": 1996,
            "title": "Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants",
            "volume": "129"
        },
        "b0245": {
            "authors": [
                {
                    "first": "Heinz J.",
                    "initial": "H.J.",
                    "last": "Schmitt"
                },
                {
                    "first": "Carl H.Wirsing",
                    "initial": "C.H.W.",
                    "last": "Von K\u00f6nig"
                },
                {
                    "first": "Albrecht",
                    "initial": "A.",
                    "last": "Neiss"
                },
                {
                    "first": "Hugues",
                    "initial": "H.",
                    "last": "Bogaerts"
                },
                {
                    "first": "Hans L.",
                    "initial": "H.L.",
                    "last": "Bock"
                },
                {
                    "first": "Hermann",
                    "initial": "H.",
                    "last": "Schulte-Wissermann"
                },
                {
                    "first": "Manfred",
                    "initial": "M.",
                    "last": "Gahr"
                },
                {
                    "first": "Rainer",
                    "initial": "R.",
                    "last": "Schult"
                },
                {
                    "first": "Jens U.",
                    "initial": "J.U.",
                    "last": "Folkens"
                },
                {
                    "first": "Wolfgang",
                    "initial": "W.",
                    "last": "Rauh"
                },
                {
                    "first": "Ralf",
                    "initial": "R.",
                    "last": "Clemens"
                }
            ],
            "doi": "10.1001/jama.275.1.37",
            "firstpage": "37",
            "issn": "00987484",
            "lastpage": "41",
            "pmid": "8531284",
            "pub_year": 1996,
            "title": "Efficacy of acellular pertussis vaccine in early childhood after household exposure",
            "volume": "275"
        }
    },
    "body_text": [
        {
            "endOffset": 25616,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "This phase III, randomized, controlled study was conducted between January 2013 and January 2014 in 1 center in the Dominican Republic, 7 centers in Germany, and 7 centers in the Republic of Korea.",
            "startOffset": 25419,
            "title": "Study design and participants"
        },
        {
            "endOffset": 44749,
            "parents": [],
            "secId": "s0080",
            "sentence": "MW and BC are employees of the GSK group of companies.",
            "startOffset": 44695,
            "title": "Declaration of interest"
        },
        {
            "endOffset": 24105,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 24020,
                    "startOffset": 24017
                },
                "b0085": {
                    "endOffset": 24104,
                    "startOffset": 24100
                }
            },
            "secId": "s0005",
            "sentence": "While IMD incidence is highest in young children with a second peak in 12\u201319-year olds [4], meningococcal carriage and transmission are the most important in adolescents [17].",
            "startOffset": 23930,
            "title": "Introduction"
        },
        {
            "endOffset": 30171,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Large swelling reactions (diameter >100 mm) were evaluated at the investigator\u2019s office and the details were documented.",
            "startOffset": 30051,
            "title": "Safety assessment"
        },
        {
            "endOffset": 30448,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Solicited local AEs were considered as vaccine-related; the causality of other AEs was assessed by the investigators.",
            "startOffset": 30331,
            "title": "Safety assessment"
        },
        {
            "endOffset": 35989,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "In exploratory analyses comparing the Tdap_ACWY and ACWY_Tdap groups, GMCs were higher for PRN and FHA when Tdap was administered prior to MenACWY-TT (Table 1).",
            "startOffset": 35829,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 44390,
            "parents": [],
            "secId": "s0075",
            "sentence": "MW, BC, RL and DSJ were involved in the concept/design of the study.",
            "startOffset": 44322,
            "title": "Contributors"
        },
        {
            "endOffset": 30050,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Other AEs were considered as grade 3 if they prevented normal, everyday activity.",
            "startOffset": 29969,
            "title": "Safety assessment"
        },
        {
            "endOffset": 33273,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "The criteria to demonstrate non-inferiority of immune responses to MenACWY-TT co-administered with Tdap versus its separate administration in terms of GMT ratio were met for the 4 meningococcal serogroups (Fig. 2A).",
            "startOffset": 33058,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 36232,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Pain was the most common local AE reported by 52.4%, 44.3% and 39.7% of participants at the MenACWY-TT injection site, and 67.1%, 53.8% and 67.2% of participants at the Tdap injection site in the Co-ad, ACWY_Tdap and Tdap_ACWY groups.",
            "startOffset": 35998,
            "title": "Safety"
        },
        {
            "endOffset": 43410,
            "parents": [],
            "secId": "s0065",
            "sentence": "Despite the failure to meet the non-inferiority criteria for immunogenicity for FHA and PRN, high booster responses and increases in antibody GMCs against PT, FHA and PRN may translate into prolonged antibody persistence and long-term protection.",
            "startOffset": 43164,
            "title": "Conclusion"
        },
        {
            "endOffset": 39482,
            "parents": [],
            "secId": "s0060",
            "sentence": "This study could not demonstrate the non-inferiority of Tdap with respect to its immunogenicity against the pertussis components, except for PT.",
            "startOffset": 39338,
            "title": "Discussion"
        },
        {
            "endOffset": 39099,
            "parents": [],
            "refoffsets": {
                "b0175": {
                    "endOffset": 39098,
                    "startOffset": 39091
                },
                "b0180": {
                    "endOffset": 39098,
                    "startOffset": 39091
                },
                "b0185": {
                    "endOffset": 39098,
                    "startOffset": 39091
                }
            },
            "secId": "s0060",
            "sentence": "In our study, rSBA GMTs tended to be lower for MenA compared to the other serogroups, followed by MenC, as previously observed in adolescents and adults [35\u201337].",
            "startOffset": 38938,
            "title": "Discussion"
        },
        {
            "endOffset": 35528,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "For all groups, antibody GMCs increased \u22659.1-fold for PT, \u226511.1-fold for FHA and \u226519.3-fold for PRN from pre-vaccination to 1 month post-Tdap administration, with the highest GMC value and fold increase in the Tdap_ACWY group for all 3 pertussis components (Table 1).",
            "startOffset": 35261,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 32887,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Of 692 enrolled participants (232 in Co-ad, 228 in ACWY_Tdap and 232 in Tdap_ACWY groups), 684 completed the study, 691 were included in the TVC and 671 in the ATP immunogenicity cohort (Fig. 1).",
            "startOffset": 32692,
            "title": "Demographic characteristics"
        },
        {
            "endOffset": 22683,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 22682,
                    "startOffset": 22677
                },
                "b0010": {
                    "endOffset": 22682,
                    "startOffset": 22677
                },
                "b0015": {
                    "endOffset": 22682,
                    "startOffset": 22677
                }
            },
            "secId": "s0005",
            "sentence": "Despite the availability of meningococcal conjugate vaccines, invasive meningococcal disease (IMD) remains a significant global cause of morbidity and mortality [1\u20133].",
            "startOffset": 22516,
            "title": "Introduction"
        },
        {
            "endOffset": 25201,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 25084,
                    "startOffset": 25075
                },
                "b0110": {
                    "endOffset": 25084,
                    "startOffset": 25075
                },
                "b0115": {
                    "endOffset": 25084,
                    "startOffset": 25075
                },
                "b0120": {
                    "endOffset": 25200,
                    "startOffset": 25196
                }
            },
            "secId": "s0005",
            "sentence": "In South Korea, epidemiological data are limited [7,22,23], but a recent study on meningococcal carriage showed that MenB followed by MenC are the most common serogroups [24].",
            "startOffset": 25026,
            "title": "Introduction"
        },
        {
            "endOffset": 23930,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 23375,
                    "startOffset": 23372
                },
                "b0045": {
                    "endOffset": 23527,
                    "startOffset": 23521
                },
                "b0050": {
                    "endOffset": 23527,
                    "startOffset": 23521
                },
                "b0055": {
                    "endOffset": 23622,
                    "startOffset": 23618
                },
                "b0060": {
                    "endOffset": 23696,
                    "startOffset": 23692
                },
                "b0065": {
                    "endOffset": 23838,
                    "startOffset": 23834
                },
                "b0070": {
                    "endOffset": 23865,
                    "startOffset": 23861
                },
                "b0075": {
                    "endOffset": 23929,
                    "startOffset": 23922
                },
                "b0080": {
                    "endOffset": 23929,
                    "startOffset": 23922
                }
            },
            "secId": "s0005",
            "sentence": "Three quadrivalent meningococcal conjugate vaccines are currently available [8]: MenACWY-TT (Nimenrix, Pfizer) using tetanus (T) toxoid as carrier protein, which is indicated for individuals from the age of 6 weeks in Europe [9,10]; MenACWY-DT (Menactra, Sanofi Pasteur Inc.) with diphtheria (D) toxoid as carrier protein [11], for individuals aged 9 months to 55 years in the United States (US) [12]; and MenACWY-CRM197 (Menveo, GSK), using diphtheria CRM197 protein as carrier protein, for individuals from the age of 2 years in Europe [13], Canada and Australia [14], and for infants from 2 months up to 55 years in the US [15,16].",
            "startOffset": 23296,
            "title": "Introduction"
        },
        {
            "endOffset": 26171,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The study was partially-blind as the Co-ad group had only 1 vaccination visit.",
            "startOffset": 26093,
            "title": "Study design and participants"
        },
        {
            "endOffset": 29846,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "All solicited local (pain, redness and swelling at injection site) and general (fatigue, fever, gastrointestinal symptoms and headache) adverse events (AEs) were evaluated during 4 days, and all unsolicited AEs during 31 days, following each vaccination.",
            "startOffset": 29592,
            "title": "Safety assessment"
        },
        {
            "endOffset": 32551,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Antibody titers/concentrations below assay cut-offs were given arbitrary values of half the cut-offs for GMT/GMC calculations.",
            "startOffset": 32425,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 25379,
            "parents": [],
            "secId": "s0005",
            "sentence": "Targeted vaccination of adolescents may confer direct protection against peaks in disease incidence in this age group, as well as reduce transmission and render herd protection.",
            "startOffset": 25202,
            "title": "Introduction"
        },
        {
            "endOffset": 34864,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "For the pertussis antigens, the criteria to demonstrate non-inferiority of immunogenicity in terms of antibody GMCs were met for PT, but not reached for FHA and PRN (Fig. 2C).",
            "startOffset": 34689,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 32170,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The 2-sided 95% CI for group GMT/GMC ratios were calculated from an analysis of covariance model on the log10 transformation of the titers or concentrations using the pre-vaccination (Month 0) log10 transformation of the titers/ concentrations, country, age strata and the 3 vaccine groups as categorical covariates.",
            "startOffset": 31854,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 32424,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Antibody GMTs/GMCs were calculated by taking the anti-log of the mean of the log10 titer/concentration transformations.",
            "startOffset": 32305,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 34358,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Anti-D antibody GMCs were similar for all groups and increased \u226513-fold at 1 month post-Tdap administration compared to pre-vaccination levels (Table 1).",
            "startOffset": 34205,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 44957,
            "parents": [],
            "secId": "s0080",
            "sentence": "The other authors have no conflict of interest to disclose.",
            "startOffset": 44898,
            "title": "Declaration of interest"
        },
        {
            "endOffset": 37116,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Nasopharyngitis was the most common unsolicited AE across all groups.",
            "startOffset": 37047,
            "title": "Safety"
        },
        {
            "endOffset": 27075,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The study protocol and informed consent were reviewed and approved by an Independent Ethics Committee or Institutional Review Board at each center.",
            "startOffset": 26928,
            "title": "Study design and participants"
        },
        {
            "endOffset": 29968,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Redness and swelling with a diameter >50 mm and fever with oral temperature >39.5 \u00b0C were defined as grade 3 in severity.",
            "startOffset": 29847,
            "title": "Safety assessment"
        },
        {
            "endOffset": 37357,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "SAEs were reported by 3 participants in the Tdap_ACWY group (gastroenteritis and depression following Tdap vaccination and orthostatic intolerance following MenACWY-TT vaccination); no SAEs were considered as causally related to vaccination.",
            "startOffset": 37116,
            "title": "Safety"
        },
        {
            "endOffset": 34689,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Compared to pre-vaccination, anti-T antibody GMCs increased 39.2-fold in the Co-ad group, whereas the GMC increases after sequential administration of the 2 vaccines were 19- to 22-fold.",
            "startOffset": 34503,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 43163,
            "parents": [],
            "secId": "s0065",
            "sentence": "This study demonstrated the non-inferiority of MenACWY-TT co-administered with Tdap compared to their separate administration in terms of immune responses to the 4 meningococcal serogroups, diphtheria and tetanus.",
            "startOffset": 42950,
            "title": "Conclusion"
        },
        {
            "endOffset": 26245,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The composition of the vaccines is detailed in the Supplementary Text S1.",
            "startOffset": 26172,
            "title": "Study design and participants"
        },
        {
            "endOffset": 44164,
            "parents": [],
            "secId": "s0075",
            "sentence": "All authors had full access to the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.",
            "startOffset": 44019,
            "title": "Contributors"
        },
        {
            "endOffset": 28255,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Secondary objectives evaluated the percentages of participants with rSBA titers \u22651:8 and \u22651:128 and vaccine responses for each meningococcal serogroup, anti-D and anti-T antibody GMCs, and booster responses to PT, FHA and PRN; compared the immunogenicity of MenACWY-TT when given before and after Tdap, and of Tdap when given before and after MenACWY-TT; and assessed the reactogenicity and safety of the study vaccines.",
            "startOffset": 27835,
            "title": "Objectives"
        },
        {
            "endOffset": 40871,
            "parents": [],
            "secId": "s0060",
            "sentence": "Similar to our findings, in other studies that assessed the impact of concurrent vaccination of Tdap with other vaccines on its immunogenicity (e.g. MenACWY-DT; Fluarix, GSK), non-inferiority criteria were not met for PRN and/or FHA GMCs.",
            "startOffset": 40633,
            "title": "Discussion"
        },
        {
            "endOffset": 29395,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0150": {
                    "endOffset": 29394,
                    "startOffset": 29390
                }
            },
            "secId": "s0025",
            "sentence": "Anti-D and anti-T antibodies were measured by an in-house enzyme-linked immunosorbent assays (ELISA), with concentrations of 0.1 International Units/mL (IU/mL) considered as seroprotective (assays cut-offs: 0.057 IU/mL for anti-D and 0.043 IU/mL for anti-T) [30].",
            "startOffset": 29132,
            "title": "Immunogenicity assessment"
        },
        {
            "endOffset": 27835,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The co-primary objectives were assessed in a hierarchical manner to demonstrate: (1) the non-inferiority of MenACWY-TT co-administered with Tdap compared to MenACWY-TT given alone in terms of geometric mean titers (GMTs) against MenA, MenC, MenW and MenY as assessed by serum bactericidal assay using baby rabbit complement (rSBA); the non-inferiority of Tdap co-administered with MenACWY-TT compared to Tdap given alone in terms of (2) the percentage of participants with post-vaccination concentration >1 IU/ml for D and T and (3) geometric mean concentrations (GMCs) for PT, FHA and PRN.",
            "startOffset": 27245,
            "title": "Objectives"
        },
        {
            "endOffset": 40423,
            "parents": [],
            "refoffsets": {
                "b0210": {
                    "endOffset": 40422,
                    "startOffset": 40415
                },
                "b0215": {
                    "endOffset": 40422,
                    "startOffset": 40415
                }
            },
            "secId": "s0060",
            "sentence": "This type of interference was previously described as reduced immune responses due to interactions between a conjugate protein and unrelated antigens which are simultaneously or sequentially administered, and a possible mechanism is competition for the use of lymph node resources [42,43].",
            "startOffset": 40134,
            "title": "Discussion"
        },
        {
            "endOffset": 39953,
            "parents": [],
            "secId": "s0060",
            "sentence": "Although for PT and PRN, GMCs in the Tdap_ACWY group were higher than in the Co-ad group, we observed at least a 9-fold increase in the GMCs for all 3 components in the Co-ad group.",
            "startOffset": 39772,
            "title": "Discussion"
        },
        {
            "endOffset": 37521,
            "parents": [],
            "secId": "s0060",
            "sentence": "Non-inferiority of immune response to MenACWY-TT co-administered with Tdap to MenACWY-TT given alone was demonstrated for all 4 meningococcal serogroups.",
            "startOffset": 37368,
            "title": "Discussion"
        },
        {
            "endOffset": 37717,
            "parents": [],
            "secId": "s0060",
            "sentence": "However, despite high seropositivity (>90%) and vaccine response rates that were similar among groups, rSBA GMTs for each serogroup were lower in participants who received Tdap before MenACWY-TT.",
            "startOffset": 37522,
            "title": "Discussion"
        },
        {
            "endOffset": 41022,
            "parents": [],
            "refoffsets": {
                "b0220": {
                    "endOffset": 41021,
                    "startOffset": 41014
                },
                "b0225": {
                    "endOffset": 41021,
                    "startOffset": 41014
                }
            },
            "secId": "s0060",
            "sentence": "Interestingly, when co-administered with MenACWY-DT, non-inferiority criteria based on booster response were met for all 3 pertussis antigens [44,45].",
            "startOffset": 40872,
            "title": "Discussion"
        },
        {
            "endOffset": 41465,
            "parents": [],
            "refoffsets": {
                "b0165": {
                    "endOffset": 41464,
                    "startOffset": 41460
                }
            },
            "secId": "s0060",
            "sentence": "In another study, higher anti-FHA antibody GMCs were observed in toddlers who received DTaP-HBV-IPV/Hib after MenACWY-TT compared to the reverse schedule [33].",
            "startOffset": 41306,
            "title": "Discussion"
        },
        {
            "endOffset": 28576,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Functional anti-MenA, -MenC, -MenW and MenY antibodies were measured by rSBA at the Public Health England laboratory in the United Kingdom.",
            "startOffset": 28437,
            "title": "Immunogenicity assessment"
        },
        {
            "endOffset": 28763,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The percentages of participants with rSBA titers \u22651:128 were also evaluated.",
            "startOffset": 28687,
            "title": "Immunogenicity assessment"
        },
        {
            "endOffset": 33490,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Pre-vaccination, the observed percentages of participants with rSBA titers \u22651:8 and \u22651:128 were comparable between groups and were higher for MenA and MenY than for MenC and MenW (Table 1 and Supplementary Table S2).",
            "startOffset": 33274,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 34502,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "All participants were seroprotected against T and 99.6% had anti-T antibody concentrations \u22651 IU/mL at 1 month post-Tdap vaccination (Table 1).",
            "startOffset": 34359,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 25025,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 25024,
                    "startOffset": 25013
                },
                "b0025": {
                    "endOffset": 25024,
                    "startOffset": 25013
                },
                "b0100": {
                    "endOffset": 25024,
                    "startOffset": 25013
                },
                "b0105": {
                    "endOffset": 25024,
                    "startOffset": 25013
                }
            },
            "secId": "s0005",
            "sentence": "In the Dominican Republic and Germany, IMDs are mainly caused by MenB and MenC, and increases in MenW and MenY incidences have been reported [3,5,20,21].",
            "startOffset": 24872,
            "title": "Introduction"
        },
        {
            "endOffset": 33858,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Compared to pre-vaccination levels, rSBA GMTs increased \u2265147-fold for MenA, \u2265230-fold for MenC, \u2265459-fold for MenW, and \u2265227-fold for MenY at 1 month post-MenACWY-TT vaccination (Table 1).",
            "startOffset": 33670,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 42839,
            "parents": [],
            "refoffsets": {
                "b0240": {
                    "endOffset": 42838,
                    "startOffset": 42834
                }
            },
            "secId": "s0060",
            "sentence": "Moreover, antibody persistence rather than immune memory may be the key determinant for long-term protection [48].",
            "startOffset": 42725,
            "title": "Discussion"
        },
        {
            "endOffset": 42431,
            "parents": [],
            "secId": "s0060",
            "sentence": "Their reactogenicity and safety profiles were not affected by their co-administration or sequential administration.",
            "startOffset": 42316,
            "title": "Discussion"
        },
        {
            "endOffset": 28437,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Blood samples were collected at Months 0 and 1 in the Co-ad group, and at Months 0, 1 and 2 in the ACWY_Tdap and Tdap_ACWY groups (Supplementary Fig. S1).",
            "startOffset": 28283,
            "title": "Immunogenicity assessment"
        },
        {
            "endOffset": 39771,
            "parents": [],
            "secId": "s0060",
            "sentence": "In the absence of correlates of protection for pertussis antigens, the clinical relevance of this observation based on GMC ratio may be limited, especially since booster response rates over 90% were observed for the 3 pertussis antigens in the Co-ad group, similar to the Tdap_ACWY group.",
            "startOffset": 39483,
            "title": "Discussion"
        },
        {
            "endOffset": 26927,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Written informed consent/assent was obtained from each participant or participant\u2019s parent/guardian prior to enrolment, as applicable.",
            "startOffset": 26793,
            "title": "Study design and participants"
        },
        {
            "endOffset": 36924,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Following each vaccination, at least 1 unsolicited AE was reported by \u226414.7% of participants in all groups (Table 2).",
            "startOffset": 36807,
            "title": "Safety"
        },
        {
            "endOffset": 31100,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Immunogenicity analyses were performed on the according-to-protocol (ATP) immunogenicity cohort, including all evaluable participants who received the planned vaccine dose(s) at first visit and with post-vaccination immunogenicity results available for at least 1 antigen.",
            "startOffset": 30828,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 32304,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0155": {
                    "endOffset": 32303,
                    "startOffset": 32299
                }
            },
            "secId": "s0035",
            "sentence": "The 2-sided 95% CI for group difference in the percentage of participants were based on the Miettinen- Nurminen score statistic [31].",
            "startOffset": 32171,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 44321,
            "parents": [],
            "secId": "s0075",
            "sentence": "All authors reviewed and commented critically drafts of the manuscript for important intellectual content and gave final approval to submit for publication.",
            "startOffset": 44165,
            "title": "Contributors"
        },
        {
            "endOffset": 35829,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Antibody GMCs were similar between the Co-ad and ACWY_Tdap groups for PT and PRN, but higher in the ACWY_Tdap group for FHA (Table 1).",
            "startOffset": 35695,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 42724,
            "parents": [],
            "secId": "s0060",
            "sentence": "In the absence of correlates of protection for pertussis, the clinical relevance of antibody GMCs is unknown and booster responses may better reflect the actual immune responses in adolescents.",
            "startOffset": 42531,
            "title": "Discussion"
        },
        {
            "endOffset": 44581,
            "parents": [],
            "secId": "s0075",
            "sentence": "MW, BC, AJ, RL and SHC were involved in the analyses / interpretation of data.",
            "startOffset": 44503,
            "title": "Contributors"
        },
        {
            "endOffset": 24567,
            "parents": [],
            "refoffsets": {
                "b0095": {
                    "endOffset": 24566,
                    "startOffset": 24562
                }
            },
            "secId": "s0005",
            "sentence": "Since a combined diphtheria-tetanus-acellular pertussis vaccine is also given routinely during adolescence in many countries, its co-administration with MenACWY-TT may increase vaccination coverage [19].",
            "startOffset": 24364,
            "title": "Introduction"
        },
        {
            "endOffset": 44502,
            "parents": [],
            "secId": "s0075",
            "sentence": "KHK, YKK, TFS, RL, UB, SHC, DSJ, JSL and JL were contributed to the collection of data and performed the study.",
            "startOffset": 44391,
            "title": "Contributors"
        },
        {
            "endOffset": 23123,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 23122,
                    "startOffset": 23119
                }
            },
            "secId": "s0005",
            "sentence": "In Africa and Asia, MenA causes most IMD cases [4].",
            "startOffset": 23072,
            "title": "Introduction"
        },
        {
            "endOffset": 23296,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 23295,
                    "startOffset": 23292
                }
            },
            "secId": "s0005",
            "sentence": "However, implementation of mass vaccination programs with serogroup A meningococcal conjugate vaccine has led to a significant decrease of IMD caused by MenA in Africa [7].",
            "startOffset": 23124,
            "title": "Introduction"
        },
        {
            "endOffset": 29572,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Antibodies against pertussis antigens were measured by an in-house ELISA, with assay cut-offs of 2.693 IU/ml for anti-PT, 2.046 IU/ml for anti-FHA and 2.187 IU/ml for anti-PRN.",
            "startOffset": 29396,
            "title": "Immunogenicity assessment"
        },
        {
            "endOffset": 33041,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Demographic characteristics were balanced between groups (Supplementary Table S1).",
            "startOffset": 32959,
            "title": "Demographic characteristics"
        },
        {
            "endOffset": 39207,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 39146,
                    "startOffset": 39139
                },
                "b0195": {
                    "endOffset": 39146,
                    "startOffset": 39139
                },
                "b0200": {
                    "endOffset": 39146,
                    "startOffset": 39139
                },
                "b0205": {
                    "endOffset": 39167,
                    "startOffset": 39163
                }
            },
            "secId": "s0060",
            "sentence": "In other studies conducted in children [38\u201340] and adolescents [41], rSBA GMTs tended to be lower for MenC.",
            "startOffset": 39100,
            "title": "Discussion"
        },
        {
            "endOffset": 26416,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "MenACWY-TT was administered intramuscularly in the left deltoid, and Tdap in the left deltoid when given alone and the right deltoid when co-administered with MenACWY-TT.",
            "startOffset": 26246,
            "title": "Study design and participants"
        },
        {
            "endOffset": 33669,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "At 1 month post-MenACWY-TT vaccination, for each serogroup, \u226596.9% of participants had rSBA titers \u22651:8 (Table 1) and vaccine response rates ranged from 93.2% to 99.6% (Fig. 3A).",
            "startOffset": 33491,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 28686,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0125": {
                    "endOffset": 28685,
                    "startOffset": 28678
                },
                "b0130": {
                    "endOffset": 28685,
                    "startOffset": 28678
                }
            },
            "secId": "s0025",
            "sentence": "The threshold for immune response against meningococcal serogroups was defined as an rSBA titer \u22651:8 [25,26].",
            "startOffset": 28577,
            "title": "Immunogenicity assessment"
        },
        {
            "endOffset": 38230,
            "parents": [],
            "refoffsets": {
                "b0160": {
                    "endOffset": 38229,
                    "startOffset": 38225
                }
            },
            "secId": "s0060",
            "sentence": "This was also observed for the concomitant administration of MenACWY-DT with Tdap (and other vaccines) in US military personnel, which resulted in higher immune responses than the administration of MenACWY-DT alone, although post-vaccination blood samples were collected in a different interval than in our study [32].",
            "startOffset": 37912,
            "title": "Discussion"
        },
        {
            "endOffset": 32958,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Reasons for withdrawal were unrelated to AEs and are listed in Fig. 1.",
            "startOffset": 32888,
            "title": "Demographic characteristics"
        },
        {
            "endOffset": 41712,
            "parents": [],
            "refoffsets": {
                "b0235": {
                    "endOffset": 41711,
                    "startOffset": 41707
                }
            },
            "secId": "s0060",
            "sentence": "A study conducted in Finland showed that when MenACWY-TT was co-administered with measles-mumps-rubella-varicella (MMRV) vaccine, the immunogenicity of MenACWY-TT was not altered but anti-rubella GMCs were lower compared to MMRV given alone [47].",
            "startOffset": 41466,
            "title": "Discussion"
        },
        {
            "endOffset": 41305,
            "parents": [],
            "refoffsets": {
                "b0230": {
                    "endOffset": 41304,
                    "startOffset": 41300
                }
            },
            "secId": "s0060",
            "sentence": "In Hib-MenC/Y conjugate vaccine (MenHibrix, GSK)-primed toddlers, co-administration of DTaP (Infanrix, GSK) with MenACWY-TT was shown not to impact the immune response to D, T and FHA, but non-inferiority versus administration of DTaP alone was not demonstrated for PT and PRN [46].",
            "startOffset": 41023,
            "title": "Discussion"
        },
        {
            "endOffset": 43874,
            "parents": [],
            "secId": "s0070",
            "sentence": "GlaxoSmithKline Biologicals SA was the funding source and was involved in all stages of the study conduct and analysis as well as the development of the manuscript and its approval for submission.",
            "startOffset": 43678,
            "title": "Role of the funding source"
        },
        {
            "endOffset": 24291,
            "parents": [],
            "refoffsets": {
                "b0085": {
                    "endOffset": 24290,
                    "startOffset": 24286
                }
            },
            "secId": "s0005",
            "sentence": "Therefore, in addition to the primary vaccination schedule in infants and toddlers, routine meningococcal vaccination is increasingly recommended in many countries for adolescents [17].",
            "startOffset": 24106,
            "title": "Introduction"
        },
        {
            "endOffset": 38677,
            "parents": [],
            "refoffsets": {
                "b0170": {
                    "endOffset": 38676,
                    "startOffset": 38672
                }
            },
            "secId": "s0060",
            "sentence": "Tdap vaccination has been previously shown to interfere with the immune response to conjugated vaccines [34].",
            "startOffset": 38568,
            "title": "Discussion"
        },
        {
            "endOffset": 38937,
            "parents": [],
            "refoffsets": {
                "b0170": {
                    "endOffset": 38936,
                    "startOffset": 38932
                }
            },
            "secId": "s0060",
            "sentence": "The immune response to a pneumococcal CRM197-conjugate vaccine (co-administered with MenACWY-TT) was suppressed in a study in Australian adults who had received Tdap 3\u20134 weeks before, but the impact on the immune responses to MenACWY-TT was not assessed [34].",
            "startOffset": 38678,
            "title": "Discussion"
        },
        {
            "endOffset": 44694,
            "parents": [],
            "secId": "s0080",
            "sentence": "TFS reports personal fees from GlaxoSmithKline and from Pfizer outside the submitted work.",
            "startOffset": 44604,
            "title": "Declaration of interest"
        },
        {
            "endOffset": 31854,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Non-inferiority of Tdap co-administered with MenACWY-TT versus Tdap given alone in terms of immune response to D and T was confirmed if the LL of the 2-sided standardized asymptotic 95% CI for the group difference (Co-ad minus Tdap_ACWY group) in the percentage of participants with anti-D and anti-T concentrations \u22651.0 IU/mL at Month 1 was \u2265\u201310%, and in terms of immune responses to PT, FHA and PRN if the LL of the 2-sided 95% CI for the GMCs ratio (Co-ad/TdapACWY group) at Month 1 was \u22650.67.",
            "startOffset": 31358,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 26605,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Exclusion criteria included history of meningococcal disease, previous vaccination against N. meningitidis, and vaccination with Tdap-containing vaccines within 5 years preceding the study.",
            "startOffset": 26416,
            "title": "Study design and participants"
        },
        {
            "endOffset": 42939,
            "parents": [],
            "secId": "s0060",
            "sentence": "As a further drawback, the study was partially-blind, which could have impacted the safety results.",
            "startOffset": 42840,
            "title": "Discussion"
        },
        {
            "endOffset": 27232,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "A protocol summary is available at http://www.gsk-clinicalstudyregister.com (study 116705).",
            "startOffset": 27141,
            "title": "Study design and participants"
        },
        {
            "endOffset": 40632,
            "parents": [],
            "secId": "s0060",
            "sentence": "However, given the high booster responses observed for all pertussis antigens, which were similar among the 3 groups, our results primarily support the co-administration of Tdap and MenACWY-TT in adolescents.",
            "startOffset": 40424,
            "title": "Discussion"
        },
        {
            "endOffset": 38567,
            "parents": [],
            "refoffsets": {
                "b0165": {
                    "endOffset": 38566,
                    "startOffset": 38562
                }
            },
            "secId": "s0060",
            "sentence": "Moreover, a previous study showed that children aged 12\u201323 months receiving a dipththeria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine (DTaP-HBV-IPV/Hib; Infanrix hexa, GSK) before MenACWY-TT had lower rSBA GMTs, but similar seroprotection rates, compared to the reverse schedule [33].",
            "startOffset": 38231,
            "title": "Discussion"
        },
        {
            "endOffset": 29132,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0135": {
                    "endOffset": 29131,
                    "startOffset": 29124
                },
                "b0140": {
                    "endOffset": 29131,
                    "startOffset": 29124
                },
                "b0145": {
                    "endOffset": 29131,
                    "startOffset": 29124
                }
            },
            "secId": "s0025",
            "sentence": "As the use of rSBA seropositivity (assessed as titers above a certain threshold [1:8]) rates as a serological surrogate of protection is still debatable, in particular for serogroups A, W and Y, rSBA GMT ratios were employed for defining the criteria to assess non-inferiority of immune responses to each meningococcal serogroup, similarly to previous studies [27\u201329].",
            "startOffset": 28764,
            "title": "Immunogenicity assessment"
        },
        {
            "endOffset": 24871,
            "parents": [],
            "secId": "s0005",
            "sentence": "This study evaluated the immunogenicity and safety of MenACWY-TT and tetanus toxoid-reduced-diphtheria toxoid-acellular pertussis vaccine (Tdap; Boostrix, GSK) when co-administered compared to their separate administration in adolescents/young adults from the Dominican Republic, Germany and South Korea.",
            "startOffset": 24567,
            "title": "Introduction"
        },
        {
            "endOffset": 44007,
            "parents": [],
            "secId": "s0070",
            "sentence": "GlaxoSmithKline Biologicals SA also took in charge all costs associated to the development and publishing of the present manuscript.",
            "startOffset": 43875,
            "title": "Role of the funding source"
        },
        {
            "endOffset": 37911,
            "parents": [],
            "secId": "s0060",
            "sentence": "The clinical impact of this observation is unknown, especially since the GMTs tended to be higher following MenACWY-TT co-administered with Tdap than MenACWY-T alone, prior to Tdap vaccination.",
            "startOffset": 37718,
            "title": "Discussion"
        },
        {
            "endOffset": 25891,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Healthy 11\u201325-year-olds were randomly assigned (1:1:1) to the Co-ad (receiving MenACWY-TT and Tdap at Month 0), ACWY_Tdap (receiving MenACWY-TT at Month 0 and Tdap at Month 1) and Tdap_ACWY (receiving Tdap at Month 0 and MenACWY-TT at Month 1) groups (Supplementary Fig. S1).",
            "startOffset": 25616,
            "title": "Study design and participants"
        },
        {
            "endOffset": 32654,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Seropositivity/seroprotection rates, vaccine response rates and GMTs/GMCs were tabulated with 95% CIs.",
            "startOffset": 32552,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 24363,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 24362,
                    "startOffset": 24358
                }
            },
            "secId": "s0005",
            "sentence": "However, vaccine coverage is not easy to attain in this age group [18].",
            "startOffset": 24292,
            "title": "Introduction"
        },
        {
            "endOffset": 34981,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "At 1 month post-vaccination with Tdap, \u226598.2% of participants were seropositive for anti-PT, -FHA or -PRN (Table 1).",
            "startOffset": 34865,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 23071,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 23007,
                    "startOffset": 23002
                },
                "b0020": {
                    "endOffset": 22919,
                    "startOffset": 22916
                },
                "b0025": {
                    "endOffset": 23007,
                    "startOffset": 23002
                },
                "b0030": {
                    "endOffset": 23070,
                    "startOffset": 23067
                }
            },
            "secId": "s0005",
            "sentence": "In America, Europe and Australia, MenB and MenC are the most common [4], with both MenY and MenW prevalence increasing lately in Europe and Latin America [3,5] while the emergence of MenW was also reported in Australia [6].",
            "startOffset": 22848,
            "title": "Introduction"
        },
        {
            "endOffset": 35260,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Post-vaccination GMCs in all groups were >53.6, \u2265316.9 and \u2265219.2 for PT, FHA and PRN, respectively.",
            "startOffset": 35160,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 39337,
            "parents": [],
            "secId": "s0060",
            "sentence": "Immunogenicity of Tdap co-administered with MenACWY-TT was non-inferior to its separate administration for diphtheria and tetanus.",
            "startOffset": 39207,
            "title": "Discussion"
        },
        {
            "endOffset": 30578,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "With a target sample size of 600 participants, the global power to meet all primary objectives was \u226591.37%.",
            "startOffset": 30471,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 42063,
            "parents": [],
            "refoffsets": {
                "b0240": {
                    "endOffset": 41868,
                    "startOffset": 41864
                },
                "b0245": {
                    "endOffset": 42062,
                    "startOffset": 42058
                }
            },
            "secId": "s0060",
            "sentence": "The antibody levels to pertussis antigens after Tdap administration in the current study were higher than those elicited by 3 doses of DTaP in infants [48], in a trial which demonstrated good efficacy of DTaP (88.7%) following household exposure, with protection against pertussis lasting until at least the time of the recommended booster dose [49].",
            "startOffset": 41713,
            "title": "Discussion"
        },
        {
            "endOffset": 26682,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "A detailed list of exclusion criteria can be found in Supplementary Text S2.",
            "startOffset": 26606,
            "title": "Study design and participants"
        },
        {
            "endOffset": 43652,
            "parents": [],
            "secId": "s0065",
            "sentence": "Although a decreased immune response to Tdap in terms of FHA and PRN GMCs was observed, the clinical relevance of this observation is most likely limited and therefore the data support co-administration of Tdap and MenACWY-TT in adolescents.",
            "startOffset": 43411,
            "title": "Conclusion"
        },
        {
            "endOffset": 26092,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Treatment allocation was performed at the investigators\u2019 site using an internet-based randomization system, with a minimization algorithm accounting for center and age stratum (11\u201317 and 18\u201325 years).",
            "startOffset": 25892,
            "title": "Study design and participants"
        },
        {
            "endOffset": 36352,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Grade 3 local AEs were reported by \u22643.5% and \u22645.6% of participants at the MenACW-TT and Tdap injection sites (Fig. 4A).",
            "startOffset": 36233,
            "title": "Safety"
        },
        {
            "endOffset": 35694,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Exploratory analyses comparing the Co-ad and Tdap_ACWY groups suggested that antibody GMCs were higher in the Tdap_ACWY group than in the Co-ad group for FHA and PRN.",
            "startOffset": 35528,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 42217,
            "parents": [],
            "secId": "s0060",
            "sentence": "It is reasonable to assume that co-administration of Tdap with MenACWY-TT in adolescents will be at least as efficacious as DTaP in preventing pertussis.",
            "startOffset": 42064,
            "title": "Discussion"
        },
        {
            "endOffset": 34204,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "The percentages of participants with anti-D concentrations \u22650.1 IU/ml and \u22651 IU/ml at 1 month post-Tdap administration were \u226599.1% and \u226588.9% (Table 1).",
            "startOffset": 34052,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 30330,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Serious AEs (SAEs) and new onset of chronic illnesses (e.g., asthma, autoimmune disorders, type 1 diabetes and allergies) were documented throughout the study.",
            "startOffset": 30171,
            "title": "Safety assessment"
        },
        {
            "endOffset": 26792,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The study was conducted in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki.",
            "startOffset": 26683,
            "title": "Study design and participants"
        },
        {
            "endOffset": 30702,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Considering approximately 13% of unevaluable participants for immunogenicity, 690 participants were planned to be enrolled.",
            "startOffset": 30579,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 36807,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Fatigue was the most common general AE, reported by 32.5%, 27.2% and 28.0% of participants post-first vaccination visit in the Co-ad, ACWY_Tdap and Tdap_ACWY groups, and by 20.4% and 19.4% of participants post-second vaccination visit in the ACWY_Tdap and Tdap_ACWY groups (Fig. 4B).",
            "startOffset": 36524,
            "title": "Safety"
        },
        {
            "endOffset": 31357,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Non-inferiority of MenACWY-TT co-administered with Tdap versus MenACWY-TT given alone was demonstrated if the lower limit (LL) of the 2-sided 95% confidence interval (CI) for the rSBA GMT ratio (Co-ad/ACWY_Tdap group) at Month 1 was \u22650.5 for each serogroup.",
            "startOffset": 31100,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 34051,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Non-inferiority of Tdap co-administered with MenACWY-TT versus Tdap given alone was demonstrated for D and T in terms of percentage of participants with antibody levels above 1 IU/ml (Fig. 2B).",
            "startOffset": 33858,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 37046,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Grade 3 and vaccine-related grade 3 unsolicited AEs were reported by \u22641.3% and \u22640.4% of participants following each dose.",
            "startOffset": 36925,
            "title": "Safety"
        },
        {
            "endOffset": 42530,
            "parents": [],
            "secId": "s0060",
            "sentence": "This study was limited by the stringent non-inferiority criteria for the pertussis immune response.",
            "startOffset": 42431,
            "title": "Discussion"
        },
        {
            "endOffset": 40133,
            "parents": [],
            "secId": "s0060",
            "sentence": "The lower GMTs for PRN and FHA observed in groups where Tdap was administered either concurrently with or after MenACWY-TT vaccination may be the result of bystander interference.",
            "startOffset": 39954,
            "title": "Discussion"
        },
        {
            "endOffset": 35159,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "A booster response to PT was observed in 85.5%\u201391.0% of participants, to FHA in 93.7%\u201395.5% of participants, and to PRN in 90.8%\u201394.6% of participants in the 3 groups (Fig. 3B).",
            "startOffset": 34982,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 30827,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Safety analyses were performed on the total vaccinated cohort (TVC), including all participants who received \u22651 vaccine dose.",
            "startOffset": 30702,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 36523,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "One participant in the Co-ad group reported a large swelling reaction (110 mm) at the MenACWY-TT injection site; the participant recovered without sequelae within 4 days.",
            "startOffset": 36353,
            "title": "Safety"
        },
        {
            "endOffset": 22847,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 22774,
                    "startOffset": 22771
                },
                "b0020": {
                    "endOffset": 22846,
                    "startOffset": 22843
                }
            },
            "secId": "s0005",
            "sentence": "Although most cases are caused by serogroups A (MenA), MenB, MenC, MenW, MenX, or MenY [3], IMD epidemiology and serogroup distribution vary largely by region [4].",
            "startOffset": 22684,
            "title": "Introduction"
        },
        {
            "endOffset": 44838,
            "parents": [],
            "secId": "s0080",
            "sentence": "AJ was consultant of XPE Pharma and Science for GSK at the time the study was conducted.",
            "startOffset": 44750,
            "title": "Declaration of interest"
        },
        {
            "endOffset": 44897,
            "parents": [],
            "secId": "s0080",
            "sentence": "MW declared stock ownership in the GSK group of companies.",
            "startOffset": 44839,
            "title": "Declaration of interest"
        },
        {
            "endOffset": 27140,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The study is registered at www.clinicaltrials.gov (NCT01767376).",
            "startOffset": 27076,
            "title": "Study design and participants"
        },
        {
            "endOffset": 42315,
            "parents": [],
            "secId": "s0060",
            "sentence": "Our study showed that MenACWY-TT and Tdap were well-tolerated when co-administered in adolescents.",
            "startOffset": 42217,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X18305176",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "lrp@claro.net.do",
                "first": "Luis",
                "initial": "L.",
                "last": "Rivera"
            },
            {
                "email": "t.schwarz@juliusspital.de",
                "first": "Tino F.",
                "initial": "T.F.",
                "last": "Schwarz"
            },
            {
                "email": "kaykim@ewha.ac.kr",
                "first": "Kyung Hyo",
                "initial": "K.H.",
                "last": "Kim"
            },
            {
                "email": "byelhana@korea.ac.kr",
                "first": "Yun Kyung",
                "initial": "Y.K.",
                "last": "Kim"
            },
            {
                "email": "u.behre@praxis-behre.de",
                "first": "Ulrich",
                "initial": "U.",
                "last": "Behre"
            },
            {
                "email": "sunghocha@khu.ac.kr",
                "first": "Sung Ho",
                "initial": "S.H.",
                "last": "Cha"
            },
            {
                "email": "drjo@chonbuk.ac.kr",
                "first": "Dae Sun",
                "initial": "D.S.",
                "last": "Jo"
            },
            {
                "email": "litjacob@hallym.or.kr",
                "first": "Jacob",
                "initial": "J.",
                "last": "Lee"
            },
            {
                "email": "ljinsoo@inha.ac.kr",
                "first": "Jin Soo",
                "initial": "J.S.",
                "last": "Lee"
            },
            {
                "email": "Brigitte.cheuvart@gsk.com",
                "first": "Brigitte",
                "initial": "B.",
                "last": "Cheuvart"
            },
            {
                "email": "archana.m.jastorff@gsk.com",
                "first": "Archana",
                "initial": "A.",
                "last": "Jastorff"
            },
            {
                "email": "marie.x.van-der-wielen@gsk.com",
                "first": "Marie",
                "initial": "M.",
                "last": "Van der Wielen"
            }
        ],
        "doi": "10.1016/j.vaccine.2018.04.034",
        "firstpage": "4750",
        "issn": "0264410X",
        "keywords": [
            "Co-administration",
            "Combined diphtheria-tetanus-acellular pertussis vaccine",
            "Immunogenicity",
            "Quadrivalent meningococcal conjugate vaccine",
            "Safety"
        ],
        "lastpage": "4758",
        "openaccess": "Full",
        "pub_year": 2018,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized study"
    }
}